|
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- Suppliers list
|
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- manufacturers
- ET-JQ1-OH
-
- $2140.00
-
2026-04-21
- CAS:2421153-77-5
- Purity:
- Supply Ability: 10g
|
| | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- Basic information |
| Product Name: | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- | | Synonyms: | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)-;ET-JQ1-OH;(2R)-2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,?]trideca-2(6),4,7,10,12-pentaen-9-yl]butanoic acid;(+)-JQ1 bump, acid functionalized;(R)-2-((S)-4-(4-CHLOROPHENYL)-2,3,9-TRIMETHYL-6H-THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPIN-6-YL)BUTANOIC ACID | | CAS: | 2421153-77-5 | | MF: | C21H21ClN4O2S | | MW: | 428.94 | | EINECS: | | | Product Categories: | | | Mol File: | 2421153-77-5.mol | ![6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- Structure](CAS/20211123/GIF/2421153-77-5.gif) |
| | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- Chemical Properties |
| Boiling point | 663.8±65.0 °C(Predicted) | | density | 1.44±0.1 g/cm3(Predicted) | | solubility | Soluble to 100 mM in DMSO | | pka | 4.11±0.10(Predicted) |
| | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- Usage And Synthesis |
| Uses | ET-JQ1-OH is an allele-specific BET inhibitor[1]. | | Biological Activity | (+)-JQ1 bump, acid functionalized is a BET bromodomain binding analog of (+)-JQ1 that selectively binds single point mutant form of Brd4 (Brd4BD2 L387A). Functionalized with a carboxylic acid group to enable onward chemistry. The position of the carboxylic acid group represents an 'exit vector' allowing modification without interfering with compound binding ability. | | storage | Store at -20°C | | References | [1] Bond AG, et al. Stereoselective synthesis of allele-specific BET inhibitors. Org Biomol Chem. 2020 Oct 7;18(38):7533-7539. DOI:10.1039/d0ob01165g |
| | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- Preparation Products And Raw materials |
|